TickerFactsScreenerDevelopers

HAEMONETICS CORP (HAE) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $507.62M2018: $492.01M2019: $550.04M2020: $503.97M2021: $472.62M2022: $487.69M2023: $553.56M2024: $617.51M2025: $611.87M2026: $546.44M$546.44M
2017Cost of Revenue (USD)2026
Fiscal YearCost of RevenueChange YoY
2026$546.44M-10.7%
2025$611.87M-0.9%
2024$617.51M+11.6%
2023$553.56M+13.5%
2022$487.69M+3.2%
2021$472.62M-6.2%
2020$503.97M-8.4%
2019$550.04M+11.8%
2018$492.01M-3.1%
2017$507.62M—